SEARCH RESULTS for GLAXOSMITHKLINE BIOLOGICALS SA

Recent Patent Assignments Patent Assignments - (Total found: 187)

Patent(s) Assignor(s) Orig. Assignee(s) Assignee(s) Reel/Frame

(X0) 14363387: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

(A1) 20150132333: CLOSTRIDIUM DIFFICILE TOXIN-BASED VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37951/417

(X0) 14425037: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

(A1) 20150315248: CLOSTRIDIUM DIFFICILE POLYPEPTIDES AS VACCINE

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

37951/441

(X0) 15093652: ADSORPTION OF IMMUNOPOTENTIATORS TO INSOLUBLE METAL SALTS

(A1) 20160213776: ADSORPTION OF IMMUNOPOTENTIATORS TO INSOLUBLE METAL SALTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

41868/47

(X0) 15011216: MENINGOCOCCAL VACCINE FORMULATIONS

(A1) 20160228529: MENINGOCOCCAL VACCINE FORMULATIONS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

41890/938

(X0) 15197376: INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION

(A1) 20160303215: INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

41857/86

(X0) 12665247: VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

(A1) 20100239604: VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

(B2) 9610339: VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES

BIEMANS, RALPH LEON

HERMAND, PHILIPPE VINCENT

POOLMAN, JAN

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

24585/817

(X0) 14727248: BACTERIAL OUTER MEMBRANE VESICLES

(A1) 20150258188: BACTERIAL OUTER MEMBRANE VESICLES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

41653/821

(X0) 14603935: NOVEL METHOD FOR PREVENTING OR TREATING M TUBERCULOSIS INFECTION

(A1) 20170065696: NOVEL METHOD FOR PREVENTING OR TREATING M TUBERCULOSIS INFECTION

INFECTIOUS DISEASES RESEARCH INSTITUTE

GLAXOSMITHKLINE BIOLOGICALS SA

35645/883

(X0) 15240385: INJECTABLE VACCINES AGAINST MULTIPLE MENINGOCOCCAL SEROGROUPS

(A1) 20160354457: INJECTABLE VACCINES AGAINST MULTIPLE MENINGOCOCCAL SEROGROUPS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

41466/951

(X0) 14764997: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

(A1) 20150366796: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

41068/782

(X0) 14764997: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

(A1) 20150366796: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

41068/820

(X0) 13881870: IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NUEROLOGIC DISORDERS

(A1) 20130216614: IMMUNOGENIC COMPOSITIONS AND METHODS FOR TREATING NUEROLOGIC DISORDERS

PALMANTIER, REMI

HALLE, MAXIME

LAROCQUE, DANIEL

TRIBOUT-JOVER, PASCALE

PRIEELS, JEAN-PAUL

GLAXOSMITHKLINE BIOLOGICALS SA

40953/1

(X0) 14110857: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

(A1) 20140056934: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

(B2) 8945577: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

BLAIS, NORMAND

LABBE, STEVE

POOLMAN, JAN

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

33859/400

(X0) 13163002: INFLUENZA VACCINE

(A1) 20110243987: INFLUENZA VACCINE

(B2) 9278127: INFLUENZA VACCINE

HANON, EMMANUEL JULES

STEPHENNE, JEAN

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

34015/130

8557251: NON-LIVE TRIVALENT INFLUENZA VACCINE FOR ONE-DOSE INTRADERMAL DELIVERY

GARCON, NATHALIE

SLAOUI, MONCEF MOHAMED

VAN HOECKE, CHRISTIAN

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

23406/490

(X0) 12374214: VACCINES FOR MALARIA

(A1) 20100062028: VACCINES FOR MALARIA

COHEN, JOSEPH D

MARCHAND, MARTINE

GLAXOSMITHKLINE BIOLOGICALS SA

23466/630

(X0) 11720561: Novel Device

(A1) 20080140019: Novel Device

THILLY, JACQUES

VANDECASSERIE, CHRISTIAN

GLAXOSMITHKLINE BIOLOGICALS SA

21197/771

(X0) 11570603: VACCINE AGAINST HPV16 AND HPV18 AND AT LEAST ANOTHER HPV TYPE SELECTED FROM HPV 31, 45 OR 52

(A1) 20080014220: VACCINE AGAINST HPV16 AND HPV18 AND AT LEAST ANOTHER HPV TYPE SELECTED FROM HPV 31, 45 OR 52

(B2) 7758866: VACCINE AGAINST HPV16 AND HPV18 AND AT LEAST ANOTHER HPV TYPE SELECTED FROM HPV 31, 45 OR 52

DEBRUS, SERGE

MARTIN, MARIE-THERESE

STEPHENNE, JEAN

WETTENDORFF, MARTINE ANNE CECILE

STEPHEN, ROBERT JOHN

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

18896/102

(X0) 11067260: Hybrid expression of neisserial proteins

(A1) 20060051840: Hybrid expression of neisserial proteins

(B2) 9267163: Hybrid expression of neisserial proteins

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40254/557

(X0) 14727248: BACTERIAL OUTER MEMBRANE VESICLES

(A1) 20150258188: BACTERIAL OUTER MEMBRANE VESICLES

NOVARTIS VACCINES AND DIAGNOSTICS SRL

GLAXOSMITHKLINE BIOLOGICALS SA

40254/588

8163296: DIMENSIONAL ANALYSIS OF SACCHARIDE CONJUGATES WITH GPC & SEC-MALS

NOVARTIS VACCINES AND DIAGNOSTICS SRL

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

40254/677

(X0) 14961725: OUTER MEMBRANE VESICLE (OMV) VACCINE COMPRISING N. MENINGITIDIS SEROGROUP B OUTER MEMBRANE PROTEINS

(A1) 20160082098: OUTER MEMBRANE VESICLE (OMV) VACCINE COMPRISING N. MENINGITIDIS SEROGROUP B OUTER MEMBRANE PROTEINS

NOVARTIS VACCINES AND DIAGNOSTICS SRL

GLAXOSMITHKLINE BIOLOGICALS SA

40254/739

(X0) 13378391: RECOMBINANT RSV VACCINES

(A1) 20120093847: RECOMBINANT RSV VACCINES

(B2) 9492531: RECOMBINANT RSV VACCINES

BAUDOUX, GUY JEAN MARIE FERNAND PIERRE

RUELLE, JEAN-LOUIS

BLAIS, NORMAND

CYR, SONYA L

RHEAULT, PATRICK

N/A

28095/134

(X0) 15046908: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

(A1) 20160250313: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

BLAIS, NORMAND

LABBE, STEVE

POOLMAN, JAN

GLAXOSMITHKLINE BIOLOGICALS SA

38526/74

(X0) 15033946: SALMONELLA CONJUGATE VACCINES

(A1) 20160263213: SALMONELLA CONJUGATE VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38513/895

(X0) 12103136: INFLUENZA VACCINE

(A1) 20090136543: INFLUENZA VACCINE

(B2) 9452209: INFLUENZA VACCINE

BALLOU, WILLIAM RIPLEY

HANON, EMMANUEL JULES

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

22123/518

(X0) 11587101: Combined Meningococcal Conjugates With Common Carrier Protein

(A1) 20080254057: Combined Meningococcal Conjugates With Common Carrier Protein

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39886/942

(X0) 14407987: VACCINES FOR SEROGROUP X MENINGOCOCCUS

(A1) 20160166674: VACCINES FOR SEROGROUP X MENINGOCOCCUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39892/920

(X0) 14002700: COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

(A1) 20140112950: COMBINATION VACCINES WITH LOWER DOSES OF ANTIGEN AND/OR ADJUVANT

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/66

(X0) 13640832: BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF

(A1) 20130122042: BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/113

(X0) 13516227: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

(A1) 20130101629: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

(B2) 9408907: HOMOGENOUS SUSPENSION OF IMMUNOPOTENTIATING COMPOUNDS AND USES THEREOF

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/143

(X0) 11913765: IMMUNOGENS FOR MENINGITIDIS-A VACCINES

(A1) 20090304734: IMMUNOGENS FOR MENINGITIDIS-A VACCINES

(B2) 8062641: IMMUNOGENS FOR MENINGITIDIS-A VACCINES

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/175

8895516: Modified saccharides, conjugates thereof, and their manufacture

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/202

(X0) 10564474: Ultrafiltration for preparing outer membrane vesicles

(A1) 20070087017: Ultrafiltration for preparing outer membrane vesicles

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/235

8568734: Method for generating immune responses utilizing nucleic acids encoding fusion proteins comprising CD4 minimal modules and invasin polypeptides that are capable of binding to the HIV envelope and exposing cryptic neutralization epitopes.

8206720: FUSION PROTEINS COMPRISING CD4 MINIMAL MODULES AND INVASIN POLYPEPTIDES THAT ARE CAPABLE OF BINDING TO THE HIV ENVELOPE AND EXPOSING CRYPTIC NEUTRALIZIATION EPITOPES.

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/283

(X0) 10576732: STABILISED COMPOSITIONS

(A1) 20070110809: STABILISED COMPOSITIONS

(B2) 7883709: STABILISED COMPOSITIONS

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/347

(X0) 11662371: Glycosylceramide Adjuvant for Saccharide Antigens

(A1) 20080199487: Glycosylceramide Adjuvant for Saccharide Antigens

(B2) 8790654: Glycosylceramide Adjuvant for Saccharide Antigens

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/376

9151756: CHLAMYDIA ANTIGENS

8568732: CHLAMYDIA ANTIGENS

NOVARTIS AG

N/A

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

39893/439

(X0) 14432848: NONLINEAR SACCHARIDE CONJUGATES

(A1) 20160101187: NONLINEAR SACCHARIDE CONJUGATES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/479

(X0) 14764997: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

(A1) 20150366796: INTRADERMAL DELIVERY OF IMMUNOLOGICAL COMPOSITIONS COMPRISING TOLL-LIKE RECEPTOR AGONISTS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/565

(X0) 14652234: CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

(A1) 20150320852: CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/620

(X0) 14775760: RNA PURIFICATION METHODS

(A1) 20160024139: RNA PURIFICATION METHODS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/668

(X0) 14786641: MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MRMBRANE ANTIGENS

(A1) 20160067326: MUTANT BACTERIA FOR PRODUCTION OF GENERALIZED MODULES FOR MRMBRANE ANTIGENS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39893/712

(X0) 14435258: NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

(A1) 20150273036: NON-CROSS-LINKED ACELLULAR PERTUSSIS ANTIGENS FOR USE IN COMBINATION VACCINES

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

39894/145

(X0) 14283727: NOVEL COMPOSITIONS AND METHODS

(A1) 20140314802: NOVEL COMPOSITIONS AND METHODS

METTENS, PASCAL

GLAXOSMITHKLINE BIOLOGICALS SA

39932/106

(X0) 12087330: ACTIVATION OF HCV-SPECIFIC T CELLS

(A1) 20100034844: ACTIVATION OF HCV-SPECIFIC T CELLS

(B2) 8178086: ACTIVATION OF HCV-SPECIFIC T CELLS

NOVARTIS VACCINE AND DIAGNOSTICS INC.

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

37539/410

(X0) 13789501: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

(A1) 20140011183: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

(B2) 9243271: FERMENTATION PROCESSES FOR CULTIVATING STREPTOCOCCI AND PURIFICATION PROCESSES FOR OBTAINING CPS THEREFROM

NOVARTIS AG

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

37560/170

(X0) 14298764: COMPOSITIONS COMPRISING PNEUMOCOCCAL ANTIGENS

(A1) 20140348868: COMPOSITIONS COMPRISING PNEUMOCOCCAL ANTIGENS

NOVARTIS AG

GLAXOSMITHKLINE BIOLOGICALS SA

38077/116

(X0) 14571546: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

(A1) 20150166613: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

(B2) 9296794: FUSION PROTEINS AND COMBINATION VACCINES COMPRISING HAEMOPHILUS INFLUENZAE PROTEIN E AND PILIN A

BLAIS, NORMAND

LABBE, STEVE

POOLMAN, JAN

N/A

GLAXOSMITHKLINE BIOLOGICALS SA

34546/620

NOVARTIS VACCINES AND DIAGNOSTICS INC

GLAXOSMITHKLINE BIOLOGICALS SA

38263/986